Canadian Cancer Trials Group (CCTG) recognizes the value and importance of engaging patients, including the patient voice in all aspects of the clinical trial life-cycle. Integrating the patient perspective into the CCTG’s overall strategic agenda ensures the research agenda has the greatest impact on cancer patients in Canada and around the world.

CCTG has implemented a model of dedicated public and patient involvement by including the Patient Representative, who are patient volunteers recruited to disease site committees similar to academic committee members with a three year extendable term.

• The role of the CCTG Patient Representative has evolved to integrate the patient perspective into many steps of the research process with the aim of:
  • research questions that matter to patients, and
  • improved accrual
• CCTG is committed to implementing best practices and materials to foster and facilitate patient engagement

If you are looking for more information about the CCTG Patient Representative Committee please contact Yvonne Murray, Patient Engagement Lead for information.

CCTG is currently looking for a volunteer for the following role: 

• To support the Gynecologic Disease Site Committee | en français

For more information about committee openings please contact Nancy Dusharm.

Priorities in cancer research

CCTG Patient Representatives participated in a facilitated workshop session to identify six research topics most important to cancer patients and caregivers. For the results >

CCTG Patient Representative Committee

Michelle Audoin 
Committee Chair

Emi Bossio
Thoracic

Bill Richardson
Head & Neck 
GenitoUrinary

Hilary Horlock
Supportive Care & QoL

Catherine Wreford
Brain

Lindsay Clarke
Genitourinary

Sally Nystrom
Melanoma & Skin

Louise Bird
DSMC

Jasmine Heuring
CEA, AYA & Sarcoma

Lesley Beaton
Gastrointestinal

Darren Frew 
Gastrointestinal

Carol Hill
IND program

Deb Clark
DSMC

Ruth Ackerman
Breast

Dawn Barker
Breast

Catherine Caule
Hematology

Tracy Kitz
Hematology